Recombinant human c-Myc protein (Active)
5
(3 Reviews)
|
(14 Publications)
Recombinant human c-Myc protein (Active) is a Human Full Length protein, in the 1 to 454 aa range, expressed in Escherichia coli, with >93% purity, 5 EU/µg endotoxin level and suitable for western blot, SDS-PAGE, Functional studies and mass spectrometry. The predicted molecular weight of ab169901 protein is 53 kDa.
- Save time and ensure accurate results - use our recombinant c-Myc protein as a control
- Optimal protein bioactivity, stability and reproducibility
- Cited in over 10 publications
View Alternative Names
BHLHE39, MYC, Myc proto-oncogene protein, Class E basic helix-loop-helix protein 39, Proto-oncogene c-Myc, Transcription factor p64, bHLHe39
Reactivity data
You may be interested in:
Why is this recommended?
We recommend this product because it’s often used in the same experiment or related research.
We advise that you always check the datasheet to ensure it fits your experiments, or contact ourtechnical teamfor help.
Product details
ab169901 is fused to an eleven arginine (11R) membrane penetration domain at the C terminus to enable penetration across the plasma membrane of mammalian cells.
Cellular Toxicity: The ab169901 recombinant protein was tested on mouse embryonic stem cells up to 50 µg/mL in culture medium. Suggested reprogramming protein concentration is between 0.5 to 8 µg/mL for both human and mouse fibroblast cells applications.
Check out our protein gel staining guide for SDS-PAGE here
Check out of western blot protocol for more information here
Sequence info
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
C-Myc is involved in regulating cell growth and proliferation. It forms part of the Myc/Max complex which binds to DNA to regulate gene expression. This activity affects cellular metabolism ribosome biogenesis and cell cycle entry emphasizing its regulation of cellular energy and stress response. Its expression levels critically govern normal cellular functions and homeostasis.
Pathways
C-Myc plays an important role in the cell cycle pathway and apoptosis regulation. Specifically c-Myc is associated with the Wnt signaling pathway which influences cellular proliferation and differentiation. It also interacts with other proteins like Cyclin D1 influencing cell cycle control. These interactions ensure c-Myc's involvement in regulating key processes related to cell proliferation and stability.
Specifications
Form
Liquid
Additional notes
ab169901 was expressed in E. coli as inclusion bodies, solubilized, refolded, and further purified.
General info
Function
Transcription factor that binds DNA in a non-specific manner, yet also specifically recognizes the core sequence 5'-CAC[GA]TG-3' (PubMed : 24940000, PubMed : 25956029). Activates the transcription of growth-related genes (PubMed : 24940000, PubMed : 25956029). Binds to the VEGFA promoter, promoting VEGFA production and subsequent sprouting angiogenesis (PubMed : 24940000, PubMed : 25956029). Regulator of somatic reprogramming, controls self-renewal of embryonic stem cells (By similarity). Functions with TAF6L to activate target gene expression through RNA polymerase II pause release (By similarity). Positively regulates transcription of HNRNPA1, HNRNPA2 and PTBP1 which in turn regulate splicing of pyruvate kinase PKM by binding repressively to sequences flanking PKM exon 9, inhibiting exon 9 inclusion and resulting in exon 10 inclusion and production of the PKM M2 isoform (PubMed : 20010808).
Post-translational modifications
Phosphorylated by PRKDC (PubMed:1597196). Phosphorylation at Ser-344 by PIM2 leads to the stabilization of MYC (By similarity). Phosphorylation at Ser-77 by CDK2 prevents Ras-induced senescence (PubMed:19966300, PubMed:20713526). Phosphorylated at Ser-77 by DYRK2; this primes the protein for subsequent phosphorylation by GSK3B at Thr-73 (PubMed:22307329). Phosphorylation at Thr-73 and Ser-77 by GSK3 is required for ubiquitination and degradation by the proteasome (PubMed:15103331, PubMed:17558397, PubMed:8386367). Dephosphorylation at Ser-77 by protein phosphatase 2A (PPP2CA) promotes its degradation; interaction with PPP2CA is enhanced by AMBRA1 (PubMed:25438055, PubMed:25803737).. Ubiquitinated by the SCF(FBXW7) complex when phosphorylated at Thr-73 and Ser-77, leading to its degradation by the proteasome (PubMed:15103331, PubMed:17558397, PubMed:25775507). In the nucleoplasm, ubiquitination is counteracted by USP28, which interacts with isoform 1 of FBXW7 (FBW7alpha), leading to its deubiquitination and preventing degradation (PubMed:17558397, PubMed:17873522). In the nucleolus, however, ubiquitination is not counteracted by USP28 but by USP36, due to the lack of interaction between isoform 3 of FBXW7 (FBW7gamma) and USP28, explaining the selective MYC degradation in the nucleolus (PubMed:17558397, PubMed:25775507). Also polyubiquitinated by the DCX(TRPC4AP) complex (PubMed:20551172, PubMed:29779948). Ubiquitinated by UBR5 when not forming a heterodimer with another bHLH protein, leading to its degradation: UBR5 recognizes and binds a degron that is only available upon heterodimer dissociation (PubMed:33208877, PubMed:37478862). Ubiquitinated by TRIM6 in a phosphorylation-independent manner (By similarity).
Subcellular localisation
Nucleus
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (14)
Recent publications for all applications. Explore the full list and refine your search
Signal transduction and targeted therapy 10:206 PubMed40588481
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cellular and molecular life sciences : CMLS 82:3 PubMed39680126
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cancers 15: PubMed37627164
2023
Applications
Unspecified application
Species
Unspecified reactive species
Pharmaceutics 15: PubMed37111592
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cancers 14: PubMed36230763
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cells 11: PubMed35406744
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in genetics 12:741867 PubMed35069677
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cell stem cell 29:298-314.e9 PubMed35045331
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cell chemical biology 28:4-13.e17 PubMed32966806
2020
Applications
Unspecified application
Species
Unspecified reactive species
Cancer cell 36:483-497.e15 PubMed31679823
2019
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Associated Products
Alternative Product
Proteins & Peptides
AB135024
Recombinant human c-Myc (mutated T73A) protein
proteins-peptides
recombinant-human-c-myc-mutated-t73a-protein-ab135024
0
(0 reviews)
Alternative Product
Proteins & Peptides
AB84132
Recombinant Human c-Myc protein
proteins-peptides
recombinant-human-c-myc-protein-ab84132
4
(1 reviews)
Alternative Product
Proteins & Peptides
AB166837
Human c-Myc peptide
proteins-peptides
human-c-myc-peptide-ab166837
0
(0 reviews)
Alternative Product
Proteins & Peptides
AB235798
Recombinant Human c-Myc protein (Tagged)
proteins-peptides
recombinant-human-c-myc-protein-tagged-ab235798
0
(0 reviews)
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com